Skip to main content

Want a detailed portfolio tracker?

MetaVia (MTVA) P/E (2023 - 2026)

MetaVia (MTVA) P/E from Jun 30, 2023 to Jul 21, 2026. The TTM MetaVia (MTVA) P/E is -0.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MetaVia (MTVA)

YearP/EChange
2026-0.32-82.44%
2025-1.83-58.59%
2024-4.41-85.86%
2023-31.19N/A

Comparison MetaVia (MTVA) P/E with competitors

MetaVia (MTVA) P/E is -0.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.53%
NBYStablecoin Development Corp0.00-101.34%
ENLVEnlivex Ltd0.07-123.32%
FGENFibroGen Inc0.24-174.83%
CHRSCoherus Biosciences Inc0.85-364.52%
FBIOFortress Biotech Inc0.95-395.85%
ORMPOramed Pharmaceuticals Inc1.50-568.56%
AGENAgenus Inc3.01-1038.21%
INVAInnoviva Inc3.15-1083.22%
VXRTVaxart Inc3.55-1206.58%
CRMDCorMedix Inc3.63-1231.12%
CVACCureVac N.V.4.45-1485.88%
GLPGGalapagos NV4.86-1614.69%
SRPTSarepta Therapeutics Inc4.88-1621.93%
ABEOAbeona Therapeutics Inc5.39-1779.48%
ABUSArbutus Biopharma Corp5.60-1844.36%
ZVRAZevra Therapeutics Inc5.89-1935.27%
SPROSpero Therapeutics Inc6.23-2041.63%
CGENCompugen Ltd6.31-2068.29%
RIGLRigel Pharmaceuticals6.87-2242.28%
SLXNSilexion Therapeutics Corp7.30-2374.46%
OMEROmeros Corporation9.26-2986.30%
AUPHAurinia Pharmaceuticals Inc9.58-3087.99%
PLXProtalix BioTherapeutics Inc10.89-3495.13%
ACADAcadia Pharmaceuticals Inc11.73-3756.22%
TBPHTheravance Biopharma Inc12.26-3922.57%
ADMAAdma Biologics Inc12.42-3971.20%
HRMYHarmony Biosciences Holdings Inc13.82-4408.28%
SABSSAB Biotherapeutics Inc14.14-4506.79%
NAGENiagen Bioscience Inc14.82-4719.37%
INCYIncyte Corp15.82-5032.49%
REGNRegeneron Pharmaceuticals Inc15.86-5043.12%
PBYIPuma Biotechnology Inc17.32-5497.96%
CPRXCatalyst Pharmaceuticals Inc17.44-5536.49%
EXELExelixis Inc17.54-5567.26%
TGTXTG Therapeutics Inc18.97-6012.44%
MDXGMimedx Group Inc20.55-6507.00%
XOMAXOMA Royalty Corp22.87-7231.10%
ARGXArgen X SE24.30-7674.81%
CTMXCytomX Therapeutics Inc24.82-7837.89%
XOMAOXOMA Royalty Corp25.34-8001.15%
HALOHalozyme Therapeutics Inc25.62-8088.10%
XOMAPXOMA Royalty Corp25.67-8102.56%
VRTXVertex Pharmaceuticals Inc27.99-8827.25%
RPRXRoyalty Pharma plc - Class A28.69-9043.23%
SLNOSoleno Therapeutics Inc29.02-9145.42%
ASNDAscendis Pharma A/S30.09-9479.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-11918.93%
APLSApellis Pharmaceuticals Inc39.02-12264.72%
BMRNBiomarin Pharmaceutical Inc42.21-13259.39%
KRYSKrystal Biotech Inc45.34-14235.66%
ONCBeiGene Ltd69.54-21778.98%
PHARPharming Group N.V.75.03-23488.96%
TECHBio-Techne Corp101.96-31885.17%
VCELVericel Corp109.92-34367.59%
ALNYAlnylam Pharmaceuticals Inc117.96-36875.21%
GMABGenmab140.29-43835.15%
TLXTelix Pharmaceuticals Ltd162.15-50650.58%
CORTCorcept Therapeutics Inc212.86-66457.58%